Read More Pharma Industry News Outlook Therapeutics trims workforce by 23% to fund Lytenava launch Outlook Therapeutics, a biopharmaceutical company specialising in retina disease treatments, has announced a 23% workforce reduction as part… byPallavi MadhirajuDecember 14, 2024